JP2024538792A - 無血清浮遊培養に適したhek293細胞株及びその応用 - Google Patents

無血清浮遊培養に適したhek293細胞株及びその応用 Download PDF

Info

Publication number
JP2024538792A
JP2024538792A JP2024522383A JP2024522383A JP2024538792A JP 2024538792 A JP2024538792 A JP 2024538792A JP 2024522383 A JP2024522383 A JP 2024522383A JP 2024522383 A JP2024522383 A JP 2024522383A JP 2024538792 A JP2024538792 A JP 2024538792A
Authority
JP
Japan
Prior art keywords
cells
medium
cell
serum
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024522383A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538792A5 (cg-RX-API-DMAC7.html
Inventor
ヤン、ワン
シャオ、パン
ロンナ、ディン
アージン、フウェイ
チュンリン、スアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Genscript Probio Biotech Co Ltd
Original Assignee
Jiangsu Genscript Probio Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Genscript Probio Biotech Co Ltd filed Critical Jiangsu Genscript Probio Biotech Co Ltd
Publication of JP2024538792A publication Critical patent/JP2024538792A/ja
Publication of JP2024538792A5 publication Critical patent/JP2024538792A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2024522383A 2021-10-12 2022-10-12 無血清浮遊培養に適したhek293細胞株及びその応用 Pending JP2024538792A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202111190063 2021-10-12
CN202111190063.4 2021-10-12
PCT/CN2022/124873 WO2023061409A1 (zh) 2021-10-12 2022-10-12 适应无血清悬浮培养的hek293细胞株及其应用

Publications (2)

Publication Number Publication Date
JP2024538792A true JP2024538792A (ja) 2024-10-23
JP2024538792A5 JP2024538792A5 (cg-RX-API-DMAC7.html) 2025-12-05

Family

ID=85987273

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024522383A Pending JP2024538792A (ja) 2021-10-12 2022-10-12 無血清浮遊培養に適したhek293細胞株及びその応用

Country Status (6)

Country Link
US (1) US20240425880A1 (cg-RX-API-DMAC7.html)
EP (1) EP4417689A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024538792A (cg-RX-API-DMAC7.html)
KR (1) KR20240070587A (cg-RX-API-DMAC7.html)
CN (1) CN118660958A (cg-RX-API-DMAC7.html)
WO (1) WO2023061409A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121586778A (zh) * 2023-04-26 2026-02-27 赛诺菲 宿主细胞系以及用于鉴定和使用此类宿主细胞系的方法
CN117089514A (zh) * 2023-10-13 2023-11-21 思鹏生物科技(苏州)有限公司 提升hek293细胞系aav生产效率的细胞筛选驯化方法
CN117402817B (zh) * 2023-10-31 2024-09-27 山东丽山生物科技有限公司 一种无血清培养驯化贴壁293t细胞的方法及其应用
WO2025171001A1 (en) 2024-02-06 2025-08-14 Regeneron Pharmaceuticals, Inc. Compositions and methods for improved production of aav viral vectors
CN118222630B (zh) * 2024-05-23 2024-08-27 江西赛基生物技术有限公司 一种稳转表达cd16跨膜蛋白细胞系的构建方法及应用
CN119639654B (zh) * 2024-12-24 2025-10-31 华元(上海)生物医药有限公司 一种人胚胎肾单克隆细胞株及其在生产慢病毒载体中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102604889A (zh) * 2012-03-19 2012-07-25 中国农业科学院哈尔滨兽医研究所 适应无血清培养的hek293细胞系及其应用
JP2014533516A (ja) * 2011-11-24 2014-12-15 ジェネトン 工業的な医薬用途に適合する拡張可能なレンチウイルスベクター製造システム
JP2016512700A (ja) * 2013-03-15 2016-05-09 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia 無血清懸濁培養物系で組み換えレンチウイルスベクターを産生するための拡張可能な生産プロセス
CN110713971A (zh) * 2019-11-06 2020-01-21 深圳市菲鹏生物治疗股份有限公司 一种无血清悬浮培养型293t细胞、其制备方法以及病毒的包装方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104450607B (zh) * 2014-11-14 2017-07-11 武汉金开瑞生物工程有限公司 用于hek293细胞悬浮生长的全化学成分培养基及培养方法
WO2022143623A1 (zh) * 2020-12-29 2022-07-07 江苏金斯瑞蓬勃生物科技有限公司 高分散性的hek293t细胞株及其筛选方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014533516A (ja) * 2011-11-24 2014-12-15 ジェネトン 工業的な医薬用途に適合する拡張可能なレンチウイルスベクター製造システム
CN102604889A (zh) * 2012-03-19 2012-07-25 中国农业科学院哈尔滨兽医研究所 适应无血清培养的hek293细胞系及其应用
JP2016512700A (ja) * 2013-03-15 2016-05-09 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia 無血清懸濁培養物系で組み換えレンチウイルスベクターを産生するための拡張可能な生産プロセス
CN110713971A (zh) * 2019-11-06 2020-01-21 深圳市菲鹏生物治疗股份有限公司 一种无血清悬浮培养型293t细胞、其制备方法以及病毒的包装方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HUMAN GENE THERAPY METHODS, vol. 28, no. 6, JPN6026025361, 2017, pages 330 - 339, ISSN: 0005892262 *
MOLECULAR THERAPY, vol. 24, no. 2, JPN6026025360, 2016, pages 287 - 297, ISSN: 0005892261 *

Also Published As

Publication number Publication date
US20240425880A1 (en) 2024-12-26
EP4417689A4 (en) 2025-10-15
KR20240070587A (ko) 2024-05-21
EP4417689A1 (en) 2024-08-21
WO2023061409A1 (zh) 2023-04-20
CN118660958A (zh) 2024-09-17

Similar Documents

Publication Publication Date Title
JP7561788B2 (ja) 臨床使用に適した無血清懸濁細胞培養システムにおいて組換えアデノ随伴ウイルス(aav)ベクターを産生するスケーラブルな方法
EP4417689A1 (en) Hek293 cell line adapted to serum-free suspension culture and use thereof
JP7801093B2 (ja) 細胞トランスフェクション及び/又はrAAVベクター産生の改善のための増強剤
JP7846625B2 (ja) 組換えaavの産生
CN104520421A (zh) 用于生产腺伴随病毒的细胞系
WO2011097447A2 (en) Production of recombinant virus
US20260139234A1 (en) Method for the production of recombinant aav particle preparations
US20240279682A1 (en) AAV Manufacturing Methods
WO2024143440A1 (ja) アデノ随伴ウイルスの製造方法、およびベクターのセット
HK40117756A (en) Method for producing recombinant aav particles
HK40117143A (en) Method for producing recombinant aav particles
WO2026020116A1 (en) Methods and compositions for enriching the production of dna cargo loaded recombinant adeno-associated virus capsids
WO2025047766A1 (ja) ウイルスの製造方法および細胞への核酸導入方法
WO2025168663A1 (en) Method for producing recombinant adeno-associated viral particles
TW202405182A (zh) 生產重組aav顆粒之方法
HK40081423A (en) Recombinant aav production

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251010

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251010

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260623